🇺🇸 SECFold Holdings, Inc.Qwen · 实盘不做把握 2/10不做原因:无法执行
北京时间·🕒 发布 05:00:14·⟳ 抓取 14:14:57 +9h14m·⚡ 决策 09-03 14:18:27 +3m30s·54.3 天前
Fold Holdings终止2.5亿美元股权购买协议并设定10月22日特别股东大会日期
Fold Holdings为市值约2500万美元的Nasdaq Capital Market微型股,20日均成交额仅约33.5万美元,日波动率高达7.76%,无法支撑任何可执行仓位。事件本身(终止自主裁量的股权购买设施+设定已披露事项的股东大会日期)方向含义模糊,不构成明确交易催化。
📄 原文Fold Holdings, Inc.↗ 原文
----- fld-20260827.htm ----- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT R…
不做 Fold Holdings(FLD.US)
市值仅2500万美元、20日ADV约33.5万美元、日波动率7.76%,流动性极差无法执行任何有意义仓位;终止自主裁量股权购买设施方向含义模糊(去除稀释但暗示需替代融资),特别会议事项为已披露旧闻;股价处于严重下行趋势(距52周高-90%),无正期望交易机会
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Fold Holdings(FLD.US)8-K披露终止2.5亿美元股权购买设施(公司有权但无义务使用),目的是'寻求替代融资',同时设定10月22日特别股东大会日期(审议8月7日已披露事项)。该公司市值仅约2500万美元,20日ADV约33.5万美元,日波动率7.76%,股价距52周高点已跌90%。终止自主裁量设施的方向含义模糊(去除稀释悬顶但暗示需要替代融资),股东大会事项为旧闻。流动性极差使任何仓位都无法执行,无正期望交易机会。
🔎 新鲜度:最早出现 2026-09-02 · 扩散 low · price-in 风险 low ↗
主要风险
- 公司寻求'替代融资'可能意味着进一步稀释或不利融资条款
- 股价处于严重下行趋势(52周跌幅90%),基本面持续恶化
先例如何影响了这次决策
对本次决策的影响:无先例可用;鉴于标的流动性极差且事件方向模糊,先例缺失不影响AVOID结论
方向:无可比先例
涨幅量级:无
形态:无
工具执行结果 · 成功 3 · 降级 1 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 489 ms
{"result": "search_processed_events:agent query=`fld 8-k termination material agreement | fold holdings fld equity purchase facility termination | fold holdings special shareholder meeting october 2026`;结构化索引覆盖完整 72 小时;旧记录兼容扫描近 71.9/72 小时、7101 条本臂决策(完整),返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选,不能据此证明 - stock_quote 降级 stock_tools HTTP · 370 ms
{ - stock_quote 成功 stock_tools HTTP · 1,663 ms
{ - direct_instrument_candidates 成功 stock_tools HTTP · 553 ms
{
原文全文
展开原文 · 7,029 字
----- fld-20260827.htm -----
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
August 27, 2026
Fold Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-41168
86-2170416
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
2942 North 24th Street
,
Suite 115
,
#42035
Phoenix
,
Arizona
85016
(Address of principal executive offices)
(Zip Code)
(
866
)
365-3277
Registrant’s telephone number, including area code
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol(s)
Name of Each Exchange on Which
Registered
Common stock, par value $0.0001 per share
FLD
Nasdaq
Capital Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share
FLDDW
Nasdaq
Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
ITEM 1.02 TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT.
On August 27, 2026, Fold Holdings, Inc. (the "Company") delivered written notice to the investor (the "Investor") party to the Equity Purchase Facility Agreement, dated as of June 16, 2025 (the "Facility"), by and between the Company and the Investor, notifying the Investor of the Company's election to terminate the Facility. In accordance with the termination provisions of the Facility, the termination will become effective on September 3, 2026. As of the date of such notice, there were no outstanding Advance Notices (as defined in the Facility) under which the Company was obligated to issue shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), to the Investor.
As previously disclosed in the Company’s Current Report on Form 8-K filed June 17, 2025, pursuant to the Facility, the Investor had committed to purchase, subject to certain conditions and limitations, up to $250,000,000 in newly issued shares of Common Stock (the "Commitment"), which the Company had the right, but not the obligation, to draw upon from time to time in its sole discretion by delivering advance notices to the Investor. The purchase price per share for shares sold to the Investor under the Facility was calculated upon the terms described therein. In connection with entering into the Facility, the Company and the Investor also entered into a Registration Rights Agreement, dated as of June 16, 2025 (the "Registration Rights Agreement"), pursuant to which the Company agreed to file with the Securities and Exchange Commission a registration statement registering the resale by the Investor of the shares of Common Stock issuable under the Facility.
The Company terminated the Facility in order to provide the Company with the option of alternative financing. The Company did not incur any prepayment fees or penalties as a result of terminating the Facility. Upon the termination of the Facility becoming effective, the Company's obligations under the Registration Rights Agreement will also terminate in accordance with the terms thereof, except to the extent the Investor then holds any Registrable Securities (as defined in the Registration Rights Agreement), in which case the Company's obligations under the Registration Rights Agreement with respect to such Registrable Securities will survive such termination.
The foregoing description of the Facility and the Registration Rights Agreement is qualified in its entirety by reference to the full text of such agreements, copies of which are incorporated herein by reference as Exhibit 10.1 and Exhibit 10.2, respectively.
ITEM 7.01 REGULATION FD DISCLOSURE.
The Company hereby announces that its Board of Directors has set October 22, 2026 as the date of a special shareholder meeting concerning the matters previously disclosed in the preliminary proxy statement filed by the Company on August 7, 2026. The record date for such meeting will be September 4, 2026.
The information contained in Item 7.01 of this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits.
Exhibit No.
Description
10.1*^
Equity Purchase Facility Agreement, dated as of June 16, 2025, by and between the Company and the Investor (incorporated by reference to Exhibit 10.1 to that Current Report on Form 8-K filed by the Company on June 17, 2025).
10.2*^
Registration Rights Agreement, dated as of June 16, 2025, by and between the Company and the Investor (incorporated by reference to Exhibit 10.2 to that Current Report on Form 8-K filed by the Company on June 17, 2025).
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
* Certain schedules, exhibits and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of such schedules, or any section thereof, to the SEC upon request.
^ Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The registrant agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
FOLD HOLDINGS, INC.
By:
/s/ Will Reeves
Name:
Will Reeves
Title:
Chief Executive Officer
Dated: September 2, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
August 27, 2026
Fold Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-41168
86-2170416
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
2942 North 24th Street
,
Suite 115
,
#42035
Phoenix
,
Arizona
85016
(Address of principal executive offices)
(Zip Code)
(
866
)
365-3277
Registrant’s telephone number, including area code
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol(s)
Name of Each Exchange on Which
Registered
Common stock, par value $0.0001 per share
FLD
Nasdaq
Capital Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share
FLDDW
Nasdaq
Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
ITEM 1.02 TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT.
On August 27, 2026, Fold Holdings, Inc. (the "Company") delivered written notice to the investor (the "Investor") party to the Equity Purchase Facility Agreement, dated as of June 16, 2025 (the "Facility"), by and between the Company and the Investor, notifying the Investor of the Company's election to terminate the Facility. In accordance with the termination provisions of the Facility, the termination will become effective on September 3, 2026. As of the date of such notice, there were no outstanding Advance Notices (as defined in the Facility) under which the Company was obligated to issue shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), to the Investor.
As previously disclosed in the Company’s Current Report on Form 8-K filed June 17, 2025, pursuant to the Facility, the Investor had committed to purchase, subject to certain conditions and limitations, up to $250,000,000 in newly issued shares of Common Stock (the "Commitment"), which the Company had the right, but not the obligation, to draw upon from time to time in its sole discretion by delivering advance notices to the Investor. The purchase price per share for shares sold to the Investor under the Facility was calculated upon the terms described therein. In connection with entering into the Facility, the Company and the Investor also entered into a Registration Rights Agreement, dated as of June 16, 2025 (the "Registration Rights Agreement"), pursuant to which the Company agreed to file with the Securities and Exchange Commission a registration statement registering the resale by the Investor of the shares of Common Stock issuable under the Facility.
The Company terminated the Facility in order to provide the Company with the option of alternative financing. The Company did not incur any prepayment fees or penalties as a result of terminating the Facility. Upon the termination of the Facility becoming effective, the Company's obligations under the Registration Rights Agreement will also terminate in accordance with the terms thereof, except to the extent the Investor then holds any Registrable Securities (as defined in the Registration Rights Agreement), in which case the Company's obligations under the Registration Rights Agreement with respect to such Registrable Securities will survive such termination.
The foregoing description of the Facility and the Registration Rights Agreement is qualified in its entirety by reference to the full text of such agreements, copies of which are incorporated herein by reference as Exhibit 10.1 and Exhibit 10.2, respectively.
ITEM 7.01 REGULATION FD DISCLOSURE.
The Company hereby announces that its Board of Directors has set October 22, 2026 as the date of a special shareholder meeting concerning the matters previously disclosed in the preliminary proxy statement filed by the Company on August 7, 2026. The record date for such meeting will be September 4, 2026.
The information contained in Item 7.01 of this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits.
Exhibit No.
Description
10.1*^
Equity Purchase Facility Agreement, dated as of June 16, 2025, by and between the Company and the Investor (incorporated by reference to Exhibit 10.1 to that Current Report on Form 8-K filed by the Company on June 17, 2025).
10.2*^
Registration Rights Agreement, dated as of June 16, 2025, by and between the Company and the Investor (incorporated by reference to Exhibit 10.2 to that Current Report on Form 8-K filed by the Company on June 17, 2025).
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
* Certain schedules, exhibits and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of such schedules, or any section thereof, to the SEC upon request.
^ Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The registrant agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
FOLD HOLDINGS, INC.
By:
/s/ Will Reeves
Name:
Will Reeves
Title:
Chief Executive Officer
Dated: September 2, 2026
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。